SING, AEGY, PROW & Extended Watchlist

 Singlepoint, Inc. SING

SING was on the move Friday, following some exciting news (below) and we placed it on our Stock Tracker which you can find in the sidebar of our blog at BlueHorseshoeStocks.com.  This is a good example of why we recommend visits to our site regularly, even if you’ve already received our daily report in your inbox. There is often content that gets added to the site throughout the course of the day, so keep that it mind!

Additionally, SING was discussed in our live trading chatroom, which is open to anyone with an interest in stocks, and a Skype connection. If you’d like an invite to the chat, send a Skype contact request to username: stocksumo

The following images show some of Friday’s chat activity on SING:


Indeed we are seeing the gap-up that we expected, this morning pre-market trades have gone off as high as a nickel. After such a huge spike, we wouldn’t be looking to jump in head-first, as a dip-and-rip scenario is exceedingly common in these situations. The resulting bounceplay could still provide traders with ample opportunity. Being another cannabis-related stock, SING is sure to be on our radar well into the future.

PHOENIX, AZ–(Marketwired – Jan 31, 2014) – SinglePoint, Inc. (OTC: SING), a state-of-the-art mobile technology and full-service mobile marketing company, announced today that it has developed a fully functional mobile payment system branded for the Cannabis and Medical Marijuana Industry — Mobile Cannabis Currency. Concurrently SinglePoint is developing point-of-sale mobile payment systems for use by cannabis dispensaries. This system is based on payment technologies used in the field for other business applications.

SinglePoint also provides text message marketing and notifications. This will enable cannabis establishments to send out messages informing their clients of the latest inventory and new products or services. Due to the nature of the industry, SinglePoints’ mobile marketing technology — the opportunity to market directly to their target market — will be a large benefit to Cannabis and Medical Marijuana providers. >>> FULL PR


Alternative Energy Partners, Inc. AEGY

Speaking of momentum plays that were running on Friday, we saw AEGY (which had already afforded us cumulative gains approaching 200% earlier in the week) run from .0036 to a high of .0078. This morning, the stock has breached a penny in pre-market trading, presumably over continued excitement with Friday’s PR regarding the readiness of the company’s online marijuana dispensary. With the monster swings AEGY has been making since we first began talking a lot about it  last Monday, we’ll need to watch closely.

LOS ANGELES, CA, Jan 31, 2014 (Marketwired via COMTEX) — Alternative Energy Partners (OTCBB: AEGY) (OTCQB: AEGY), known as PharmaJanes (“the Company”), is pleased to announce that PharmaJanes.com, the e-commerce servicing platform, is now open for new patient enrollment. PharmaJanes will first begin servicing parts of metropolitan Southern California, and thereafter will expand throughout California in phases. At the appropriate time, PharmaJanes intends to roll out nationwide. >> FULL PR


Progress Watch Corp. PROW

PROW has been a superstar since we began talking about it heavily beginning on December 20th, when we caught it at a low of .0065. From the very start, we were looking for a Golden Cross formation on the chart to signify upcoming gains, and we were not disappointed in the slightest. The stock went on to hit a high of .079 just three weeks later, a mind-numbing move of 1115%

Since that peak we’ve seen PROW undergo some routine consolidation, and it seems to have established itself a base of support around four cents, so we want to call attention back to it as the time for another swing may soon be drawing near.


Extended Watchlist:
KTOS, NBG, GIG, RITT, PGNX, IPCI, BEAT, CTIC

ERBB, FITX, PROW, REVI & Extended Watchlist

Tranzbyte Corp. ERBB

Turning our focus back to cannabis stocks yesterday proved to be a good decision, as more than a couple of them put up great performances on the day. Among those most impressive was ERBB, a stock that we’ve had on our radar for well over a year now.

During the ‘Green Rush’ that took place the first week of this year, we saw the stock shoot from the .002-range up to .0146. Upon pulling back, it found support and bounced from .0056, and made its way back as high as .011. It would pull back one more time, to .0063, before hitting a high of .0118 yesterday on extremely high volume. It’s safe to say that ERBB has brought us a host of huge gain opportunities in just the past few weeks.

We want to continue to keep an eye on ERBB. To find out why, take a look at the following video chart we’ve prepared:

Yesterday’s News:


Creative Edge Nutrition, Inc. FITX

FITX continued to breakout following yesterday’s report, trading immense volume (350M shares) to the tune of roughly 5X its 3mo. average, and hitting a high of .0648.

We ran across an interesting article regarding federal regulations for banks who wish to lend to marijuana-related companies. Attorney General Eric Holder announced that the fed intends to make it easier for banks to deal with these companies in the past. That means companies like FITX and many of the others we’ve talked about should be able to open up avenues toward better funding. >>>READ ARTICLE


Progress Watch Corp. PROW

Our recent favorite, PROW, continued to provide ample opportunities yesterday as it opened up trading as low as .0315, before touching a daily high of .079, a 151% intraday spike. From the low following our initial alert (.0067) on December 20th, PROW had seen a monumental increase of 1080% at yesterday’s high.


Resource Ventures, Inc. REVI

Yesterday, REVI touched a new high since we’ve been following it, at .011. That marks an overall gain of up to 49% since our initial report on Tuesday. It traded better-than-average volume, and maintained the support we were looking to see held at .0085.

We’re still waiting for the potential upcoming Golden Cross that appears to be forming on the REVI chart.


Options Trading Idea: TSLA $175 and $180 Weekly Calls for possible daytrading opportunity.


Extended Watchlist:
LUNA, KOOL, BDSI, ADMP


PROW, REVI & Extended Watchlist

Progress Watch Corp. PROW

We first introduced PROW to our reports on December 20th, when it was trading at a low of .0065. At that time, we pointed out the likelihood of a Golden Cross, and witnessed one just a couple weeks later. That signaled what would turn out to be an astonishingly impressive week-long breakout to a high of .0488, a rise of 650% from our initial alert price. Quite a move, considering it only took a little over three weeks to transpire.

PROW, is also extremely relevant to yesterday’s report on REVI, because it illustrates the potential power of the elusive Golden Cross chart formation.



Resource Ventures, Inc. REVI

We were pleased with the quick-strike opportunity our alert on REVI offered us yesterday. After opening at its low of day (.0074) the stock surged to a subsequent high of .0105, affording sharp traders the chance at gains of up to 42% After receding from that initial push, the stock found support at .008, bouncing back to .009 before closing at .0087, up 17.5% on the day and trading over 30% more volume than its 3mo. average.

We consider that an extremely solid performance from a stock being mentioned in our reports for the first time, and our call of the possible bounce from the .0074-level couldn’t have been timed any better.

We’re not done following this play, however, as it appears this company is doing everything in its power to improve its process and ensure its positioning for positive growth in the future. We’ll leave the recent press highlights we outlined in yesterday’s special report intact below for anyone who might have missed it; we’re looking forward to seeing how the company follows through with everything it currently has in the works. We also have the impending Golden Cross angle to follow, as we mentioned above; REVI is even closer to its potential Golden Cross than PROW was when we first mentioned it. So the potential for further gains in the days and weeks to come is certainly present. While past performances are no guarantee of future results, we’ve seen the Golden Cross scenario play out so many times to a positive effect, that we would be remiss not to point it out.

We’re also looking at a fresh news release the company put out this morning:

SILVERADO CA–(Marketwired – Jan 22, 2014) – Resource Ventures, Inc. (PINKSHEETS: REVI) President Bob Thompson announced today that the Company’s wholly owned subsidiary, Resources Printing and Graphics, Inc. (RP&G) has achieved a milestone in their Promotional Products, in that the division has grown to represent more than 25% of the company’s overall revenue.

“15 years ago RP&G started their Promotional Products division to satisfy the many customer requests received on a daily basis, RP&G’s printing customers kept pressing us to take on more of their other graphic needs; they like the 24/7 service we offer, and just wanted us to do more for them,” said Bob Thompson, President of Resource Ventures Inc. “Now over a half million products are offered from pens to cups to watches; anything you want to put logo or message on, we can likely do.”

RECENT PRESS HIGHLIGHTS:

– Company expects to report over $2M in revenue for year ending 12/31/13, a year-over-year rise in in excess of 40-50% (Report due no later than 04/01)

– Planned exchange uplisting, process for which could begin as early as Q2

– Company has committed to timely release of all pertinent data while it remains on OTC Pink

– New online store “WikiClickPrint.com” in “fast-track development” mode


www.resourcesprinting.com



Extended Watchlist:
BBRY, KOOL, EVOK, MSTX, DRWI, MELA, CVM

OXBT, PROW, RNN, BYD & Extended Watchlist

Oxygen Biotherapeutics, Inc. OXBT

Our readers who have been with us since October will remember OXBT, and that we were fortunate enough to catch it at a low of 1.46 before it steamrolled its way up to 11.40, affording us the chance at gains of 681% We re-tagged it on December 19thafter the consolidation off of the initial spike brought the stock back to find a bottom at 4.20. Our timing on that alert ended being spot-on, as the pattern reversed and OXBT began to ascend once more. As of Friday, the stock had reached a high of 7.40, which represents a gain of 76% from the recent 4.20 low.High volume and a strong close at 7.35 for Friday’s session will ensure OXBT a spot on our watchlists as we kick off this new trading week.


Progress Watch Corp. PROW

We pointed out the Golden Cross in progress for PROW on Friday, and despite already having witnessed gains in excess of 515% from .0065 to Thursday’s high of .04 (Initial alert- 12/20/13) we were able to reap further profits as the stock continued to uptrend, topping out at .048 and settling back only slightly to close at .0472. That high pushed our max gains on PROW to 638% in less than a month’s time. Congrats to anyone to has been able to take advantage of this rapid-gainer.

As is the case with any stock that rises so quickly, we’ll need to execute our trades with tight stops, and be on the lookout for signs of a reversal while still remaining open to the possibility of a continued breakout.


Rexhan Pharmaceuticals, Inc. RNN

We’ve followed RNN from December 11th (Low .4026) onward, and have been duly rewarded for our persistence. Friday, we reminded everyone to be on the lookout for more solid gains, as we had already followed the stock up over 90% and were witnessing some heavy pre-market trading pushing the price even higher. RNN would go on to touch a new high for us at 1.19, which represents a gain of 196% from our initial alert low from just a month ago.

This took place on well over 15x the 3mo. average volume, with a healthy close at 1.14, so we’ll be watching RNN carefully today. Like our previously mentioned plays, RNN has been gaining a lot of ground over a short period of time, and should be monitored closely. Perhaps more so than the others, a quick peek at the chart shows it beginning to look overbought. Vigilance is key! In the event of a pullback, we’d like to see RNN hold support somewhere above the .80-level.


Boyd Gaming Corp. BYD

We want to add BYD to our watchlist today. We haven’t mentioned this one before, but are interested in both the building chart, and the sector in which the company operates. BYD operates over twenty gaming entertainment properties across Nevada, New Jersey, Illinois, Indiana, Iowa, Kansas, Louisiana and Mississippi.

Gaming stocks were a hot ticket in 2013, and with online gaming now being permitted in Nevada, Delaware, and New Jersey, some folks believe that national regulation is ‘in the cards’. The gaming sector, both online and brick-and-mortar, is going to be one to watch intently in 2014.


Extended Watchlist:
BLDR, AAPL, GOGO

PROW, RNN & Extended Watchlist

Record-Setting ‘Green Rush’ Begins to Subside
Like all good things, the frenzied buying of countless pot stocks largely came to an end during yesterday’s session. It was a historic week; an overwhelming trend caused by sheer excitement over Colorado’s precedent-setting entry into the post-prohibition era, and we were happy to cover every step, taking profits along the way! Granted, the main wave of hysteria is now over, but our continued interest in the sector as a whole will not wane. As we stated previously, this story has only just begun to be written. Even as many of the huge runners we’ve tracked began to pull back, others maintained their trends, and still others came down to find support only to rebound and provide bounce opportunities. Rest assured, we will remain hot on the trail of any possible chance at added profits within this sector that has been so good to us for so long a time. For now, it’s time to shift gears and talk about some of our other interests that were forced to the back burner in all the excitement.

Progress Watch Corp. PROW

PROW has brought us some really impressive gains in the short time that we’ve been including it in our reports. When we first began talking about it (12/20/13, trading at .0065) we were especially interested in its tight share structure. That day, we said that the 50DMA rising sharply toward the 200DMA “should lead to a golden cross in the weeks and months ahead.”  That golden cross is now in progress as the stock ran into the close yesterday, attaining four cents, an increase of 515% off of the bottom we observed just twelve trading sessions ago.

As the value of the stock increases, we’re going to be looking for support levels to hold at areas of previous resistance. In the event of any pullbacks, we would like to see support hold at .025, and below that, .013, in order to remain bullish on PROW.


Rexhan Pharmaceuticals, Inc. RNN

Back on December 11th, we tagged RNN for the first time in our extended watchlist, and were rewarded with an intraday run of 26% from .4026 to  .5179. Even as marijuana stocks were breaking out over the past couple of days, we were still tracking this stock’s impressive run via our extended watchlists, and yesterday, saw a high of .765. That marks an increase of 90% from our observed low, a figure which is being pushed even higher this morning; pre-market trades have gone off as high as .929, so things could get very interesting from here. This spike seems to have been catalyzed by a recent press announcement from RNN.


The following PR was released under the headline: “RX-3117 has Shown Efficacy Against Gemcitabine-Resistant Human Cancer Cell Lines and a Broad-Spectrum of Anti-Cancer Activity “

ROCKVILLE, Md., Jan 08, 2014 (BUSINESS WIRE) — Rexahn Pharmaceuticals, Inc. (NYSE MKT: RNN) a clinical stage biopharmaceutical company, announced today the initiation of a Phase Ib clinical trial to study the safety and efficacy of RX-3117 in cancer patients with solid tumors. RX-3117 is a next-generation cancer cell specific drug candidate that possesses a broad spectrum of anticancer activity with reduced side effects. In an exploratory Phase I clinical trial conducted in Europe, RX-3117 demonstrated oral bioavailability, and safety and tolerability in cancer patients with solid tumors. >> FULL PR


Extended Watchlist:
CNAT, BBRY, IMMU, BLDP, NSPH, RTRX

Get Our FREE Daily Reports!